Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

Researchers use several different strategies to deliver a one-two punch.

The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.

The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 

Scientists still don’t know exactly how some commonly used drugs work. Here’s a look at three such compounds.

Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
 

Scientists create a photosensitive pharmaceutical to target a glutamate receptor.

Studying and treating the chronic diseases associated with aging needs serious revamping.